| 000 | 02779 a2200877 4500 | ||
|---|---|---|---|
| 005 | 20250517020734.0 | ||
| 264 | 0 | _c20160519 | |
| 008 | 201605s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mdv106 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGourgou-Bourgade, S | |
| 245 | 0 | 0 |
_aGuidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cMay 2015 |
||
| 300 |
_a873-879 p. _bdigital |
||
| 500 | _aPublication Type: Consensus Development Conference; Journal Article; Practice Guideline; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aBreast Neoplasms _xdiagnosis |
| 650 | 0 | 4 | _aConsensus |
| 650 | 0 | 4 | _aDelphi Technique |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 |
_aEndpoint Determination _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aRandomized Controlled Trials as Topic _xclassification |
| 650 | 0 | 4 |
_aResearch Design _xstandards |
| 650 | 0 | 4 | _aTerminology as Topic |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Failure |
| 700 | 1 | _aCameron, D | |
| 700 | 1 | _aPoortmans, P | |
| 700 | 1 | _aAsselain, B | |
| 700 | 1 | _aAzria, D | |
| 700 | 1 | _aCardoso, F | |
| 700 | 1 | _aA'Hern, R | |
| 700 | 1 | _aBliss, J | |
| 700 | 1 | _aBogaerts, J | |
| 700 | 1 | _aBonnefoi, H | |
| 700 | 1 | _aBrain, E | |
| 700 | 1 | _aCardoso, M J | |
| 700 | 1 | _aChibaudel, B | |
| 700 | 1 | _aColeman, R | |
| 700 | 1 | _aCufer, T | |
| 700 | 1 | _aDal Lago, L | |
| 700 | 1 | _aDalenc, F | |
| 700 | 1 | _aDe Azambuja, E | |
| 700 | 1 | _aDebled, M | |
| 700 | 1 | _aDelaloge, S | |
| 700 | 1 | _aFilleron, T | |
| 700 | 1 | _aGligorov, J | |
| 700 | 1 | _aGutowski, M | |
| 700 | 1 | _aJacot, W | |
| 700 | 1 | _aKirkove, C | |
| 700 | 1 | _aMacGrogan, G | |
| 700 | 1 | _aMichiels, S | |
| 700 | 1 | _aNegreiros, I | |
| 700 | 1 | _aOffersen, B V | |
| 700 | 1 | _aPenault Llorca, F | |
| 700 | 1 | _aPruneri, G | |
| 700 | 1 | _aRoche, H | |
| 700 | 1 | _aRussell, N S | |
| 700 | 1 | _aSchmitt, F | |
| 700 | 1 | _aServent, V | |
| 700 | 1 | _aThürlimann, B | |
| 700 | 1 | _aUntch, M | |
| 700 | 1 | _avan der Hage, J A | |
| 700 | 1 | _avan Tienhoven, G | |
| 700 | 1 | _aWildiers, H | |
| 700 | 1 | _aYarnold, J | |
| 700 | 1 | _aBonnetain, F | |
| 700 | 1 | _aMathoulin-Pélissier, S | |
| 700 | 1 | _aBellera, C | |
| 700 | 1 | _aDabakuyo-Yonli, T S | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 26 _gno. 5 _gp. 873-879 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mdv106 _zAvailable from publisher's website |
| 999 |
_c24663368 _d24663368 |
||